Titan Pharmaceuticals Inc (de) (TTNP) EBITDA (2015 - 2025)
Titan Pharmaceuticals Inc (de) (TTNP) EBITDA from Dec 31, 2015 to Jun 30, 2025. The TTM Titan Pharmaceuticals Inc (de) (TTNP) EBITDA is -$2.61M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Titan Pharmaceuticals Inc (de) (TTNP) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -63.19% |
| 3 Years TTM | -34.22% |
| 5 Years TTM | +4.95% |
Annual EBITDA change of Titan Pharmaceuticals Inc (de) (TTNP)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$1.19M | -73.85% |
| 2024 | -$4.55M | -36.45% |
| 2023 | -$7.16M | -28.69% |
| 2022 | -$10M | +9.97% |
| 2021 | -$9.13M | +29.32% |
| 2020 | -$7.06M | -7.47% |
| 2019 | -$7.63M | -3.17% |
| 2018 | -$7.88M | -44.03% |
| 2017 | -$14M | -398.31% |
| 2016 | $4.72M | -173.75% |
| 2015 | -$6.40M | N/A |